![Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00415-021-10744-x/MediaObjects/415_2021_10744_Fig2_HTML.png)
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | Journal of Neurology
![CD20 antigen structure and organization into membrane bilayers. (A) The... | Download Scientific Diagram CD20 antigen structure and organization into membrane bilayers. (A) The... | Download Scientific Diagram](https://www.researchgate.net/publication/8482635/figure/fig1/AS:280071723077640@1443785710251/CD20-antigen-structure-and-organization-into-membrane-bilayers-A-The-CD20-protein-has.png)
CD20 antigen structure and organization into membrane bilayers. (A) The... | Download Scientific Diagram
![The reduction of B cells by anti-CD20 antibodies includes 6 mechanisms.... | Download Scientific Diagram The reduction of B cells by anti-CD20 antibodies includes 6 mechanisms.... | Download Scientific Diagram](https://www.researchgate.net/publication/329360343/figure/fig1/AS:699473705586688@1543778935149/The-reduction-of-B-cells-by-anti-CD20-antibodies-includes-6-mechanisms-1-Complement.jpg)
The reduction of B cells by anti-CD20 antibodies includes 6 mechanisms.... | Download Scientific Diagram
![B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-020-00092-2/MediaObjects/41573_2020_92_Fig1_HTML.png)
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
![Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science](https://www.eurekaselect.com/images/graphical-abstract/cdt/17/9/07.gif)
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
![Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab](https://www.mdpi.com/brainsci/brainsci-10-00758/article_deploy/html/images/brainsci-10-00758-g001.png)
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
![Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram](https://www.researchgate.net/publication/272514227/figure/fig1/AS:601758732648473@1520481870987/Mechanisms-of-action-of-anti-CD20-monoclonal-antibodies-Abbreviation-CLL-chronic.png)
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
![Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | Current Oncology Reports Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | Current Oncology Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11912-018-0748-0/MediaObjects/11912_2018_748_Fig2_HTML.png)